Sanofi launches Real Skinformation, an AI-powered website supporting healthcare professionals in tackling online skincare trends and misinformation

·         Skin conditions affect around 60% of people in the UK at some point in their lives.[i] Atopic dermatitis affects around 11 to 20% of children and 5 to 10% of adults.[ii]

·         A significant amount of information on dermatology care comes from non-medical sources, which can leave the public confused and uncertain about what advice to follow.

[Reading, 14 September 2025] In recognition of World Atopic Eczema Day, Sanofi is proud to launch Real Skinformation, an innovative AI-powered platform created for UK healthcare professionals (HCP) to effectively navigate the ever-evolving landscape of online skincare trends and misinformation.

Affecting around 60% of the UK population at some point in their lives, skin conditions affect most adults and children. In a digital age, patients with chronic skin conditions like atopic dermatitis are increasingly turning to social media platforms and online forums for skincare advice.

While some online information will be accurate, members of the public may find it difficult to distinguish credible healthcare advice from misleading, anecdotal information. With this information being surprisingly easy to access for patients, healthcare professionals may find it difficult to keep track of the information and advice making its way into patient treatment regimens.

Real Skinformation utilises advanced artificial intelligence (AI) technology to bridge this gap in access to information. Using AI, the tool analyses thousands of publicly available conversations across major social media platforms, including TikTok, YouTube, X, and Reddit.

By tapping into these everyday digital discussions, Real Skinformation identifies emerging narratives and popular skincare treatments that patients might be exposed to through social media in the UK, equipping healthcare providers with the insights needed to enable more informed, empathetic and supportive interactions.

While innovative digital tools can support awareness and dialogue, the best way to treat any skin condition remains through consultation with a qualified HCP. Too often, patients may turn to social media as an alternative to treatment or use online trends to challenge the advice of their HCPs. Through Real Skinformation, Sanofi is supporting HCPs by providing clear insights into the information patients may encounter online, helping them to contextualise emerging trends and explain where the science supports - or does not support - such claims.

Carlos Lopez, Dermatology Franchise Lead, UK & Ireland: “In today’s digital world, patients are just one click away from a flood of alternative health advice. Some if it legitimate, some of it less accurate, but all of it is surprisingly easy to access for patients and often potentially harmful for patients.

While the best way to treat any skin condition is always through consultation with a doctor, we know that patients increasingly turn to social media as a treatment alternative or to challenge the guidance of their HCP.

At Sanofi, we have been utilising AI to combat this misinformation, identifying these trends and ensuring that HCPs have access to the most up-to-date insights. By understanding what patients are being exposed to, clinicians can more confidently engage in conversations, explain the scientific accuracy - or lack thereof - behind certain claims, and ultimately support patients in making more informed decisions about their care.”

About Sanofi

Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine. We work to turn the impossible into the possible, providing life-changing treatment options and life-saving vaccine protection to millions of people worldwide – while placing sustainability and social responsibility at the heart of what we do.